MPG.eBooks - Search Results

1

New drugs for type 2 diabetes : second-line therapy -- science report

Published 2017

CADTH

Read Now

2

New drugs for type 2 diabetes : second-line therapy -- science report

Published 2017

CADTH

Read Now

3

Clinical review report: Sofosbuvir/Velpatasvir/Voxilaprevir (Vosevi) (Gilead Sciences Canada, Inc.)

Published 2018

Canadian Agency for Drugs and Technologies in Health

“...Sofosbuvir/Velpatasvir/Voxilaprevir (Vosevi) (Gilead Sciences Canada, Inc.)...”

Read Now

4

Clinical review report: Sofosbuvir/Velpatasvir/Voxilaprevir (Vosevi) (Gilead Sciences Canada, Inc.)

Published 2018

Canadian Agency for Drugs and Technologies in Health

“...Sofosbuvir/Velpatasvir/Voxilaprevir (Vosevi) (Gilead Sciences Canada, Inc.)...”

Read Now

5

CADTH Canadian Drug Expert Committee recommendation: Tenofovir alafenamide (Vemlidy -- Gilead Sciences Canada, Inc.) : indication : chronic hepatitis B.

Published 2018

CADTH

“...Tenofovir alafenamide (Vemlidy -- Gilead Sciences Canada Inc.)...”

Read Now

6

CADTH Canadian Drug Expert Committee recommendation: Sofosbuvir/Velpatasvir/Voxilaprevir (Vosevi -- Gilead Sciences Canada, Inc.)...

Published 2018

CADTH

“...Sofosbuvir/Velpatasvir/Voxilaprevir (Vosevi -- Gilead Sciences Canada, Inc.)...”

Read Now

7

Clinical review report: Bictegravir/Emtricitabine/Tenofovir alafenamide (B/FTC/TAF) (Biktarvy) (Gilead Sciences Canada, Inc.)...

Published 2018

Canadian Agency for Drugs and Technologies in Health

“...Bictegravir/Emtricitabine/Tenofovir alafenamide (B/FTC/TAF) (Biktarvy) (Gilead Sciences Canada, Inc.)...”

Read Now

8

Clinical review report: Bictegravir/Emtricitabine/Tenofovir alafenamide (B/FTC/TAF) (Biktarvy) (Gilead Sciences Canada, Inc.)...

Published 2018

Canadian Agency for Drugs and Technologies in Health

“...Bictegravir/Emtricitabine/Tenofovir alafenamide (B/FTC/TAF) (Biktarvy) (Gilead Sciences Canada, Inc.)...”

Read Now

9

Pharmacoeconomic review report: Bictegravir/Emtricitabine/Tenofovir alafenamide (B/FTC/TAF) (Biktarvy) : (Gilead Sciences Canada, Inc.)

Published 2018

Canadian Agency for Drugs and Technologies in Health

“...Bictegravir/emtricitabine/tenofovir alafenamide (B/FTC/TAF) (Biktarvy) (Gilead Sciences Canada, Inc.)...”

Read Now

10

Pharmacoeconomic review report: Bictegravir/Emtricitabine/Tenofovir alafenamide (B/FTC/TAF) (Biktarvy) : (Gilead Sciences Canada, Inc.)

Published 2018

Canadian Agency for Drugs and Technologies in Health

“...Bictegravir/emtricitabine/tenofovir alafenamide (B/FTC/TAF) (Biktarvy) (Gilead Sciences Canada, Inc.)...”

Read Now

11

CADTH Canadian Drug Expert Committee final recommendation: Emtricitabine / tenofovir alafenamide (Descovy -- Gilead Sciences Canada, Inc.) indication : HIV-1 infection

Published 2016

Canadian Agency for Drugs and Technologies in Health

Read Now

12

CADTH Canadian Drug Expert Committee final recommendation: Emtricitabine / tenofovir alafenamide (Descovy -- Gilead Sciences Canada, Inc.) indication : HIV-1 infection

Published 2016

Canadian Agency for Drugs and Technologies in Health

Read Now

13

Screening for Chlamydia trachomatis and Neisseria gonorrhoeae during pregnancy : a health technology assessment

by Kanga, Ismat
Published 2018

CADTH

Read Now

14

Screening for Chlamydia trachomatis and Neisseria gonorrhoeae during pregnancy : a health technology assessment

by Kanga, Ismat
Published 2018

CADTH

Read Now

15

New oral anticoagulants for the prevention of thromboembolic events in patients with atrial fibrillation

Published 2012

Canadian Agency for Drugs and Technologies in Health

Read Now

16

New oral anticoagulants for the prevention of thromboembolic events in patients with atrial fibrillation

Published 2012

Canadian Agency for Drugs and Technologies in Health

Narrow Search